HEADER TRANSFERASE 17-DEC-09 3L3M
TITLE PARP COMPLEXED WITH A927929
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: RESIDUES 662-1011;
COMPND 5 SYNONYM: PARP-1, ADPRT, NAD(+) ADP-RIBOSYLTRANSFERASE 1, POLY[ADP-
COMPND 6 RIBOSE] SYNTHETASE 1;
COMPND 7 EC: 2.4.2.30;
COMPND 8 ENGINEERED: YES;
COMPND 9 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PARP1, ADPRT, PPOL;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS PROTEIN-INHIBITOR COMPLEX, ACETYLATION, ADP-RIBOSYLATION, DNA DAMAGE,
KEYWDS 2 DNA REPAIR, DNA-BINDING, GLYCOSYLTRANSFERASE, METAL-BINDING, NAD,
KEYWDS 3 NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION,
KEYWDS 4 TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR C.H.PARK
REVDAT 4 03-APR-24 3L3M 1 REMARK
REVDAT 3 21-FEB-24 3L3M 1 REMARK
REVDAT 2 13-OCT-21 3L3M 1 REMARK SEQADV
REVDAT 1 23-JUN-10 3L3M 0
JRNL AUTH T.D.PENNING,G.D.ZHU,J.GONG,S.THOMAS,V.B.GANDHI,X.LIU,Y.SHI,
JRNL AUTH 2 V.KLINGHOFER,E.F.JOHNSON,C.H.PARK,E.H.FRY,C.K.DONAWHO,
JRNL AUTH 3 D.J.FROST,F.G.BUCHANAN,G.T.BUKOFZER,L.E.RODRIGUEZ,
JRNL AUTH 4 V.BONTCHEVA-DIAZ,J.J.BOUSKA,D.J.OSTERLING,A.M.OLSON,
JRNL AUTH 5 K.C.MARSH,Y.LUO,V.L.GIRANDA
JRNL TITL OPTIMIZATION OF PHENYL-SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDE
JRNL TITL 2 POLY(ADP-RIBOSE) POLYMERASE INHIBITORS: IDENTIFICATION OF
JRNL TITL 3 (S)-2-(2-FLUORO-4-(PYRROLIDIN-2-YL)PHENYL)
JRNL TITL 4 -1H-BENZIMIDAZOLE-4-CARBOXAMIDE (A-966492), A HIGHLY POTENT
JRNL TITL 5 AND EFFICACIOUS INHIBITOR.
JRNL REF J.MED.CHEM. V. 53 3142 2010
JRNL REFN ISSN 0022-2623
JRNL PMID 20337371
JRNL DOI 10.1021/JM901775Y
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 81.60
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 3 NUMBER OF REFLECTIONS : 12464
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.205
REMARK 3 R VALUE (WORKING SET) : 0.202
REMARK 3 FREE R VALUE : 0.275
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200
REMARK 3 FREE R VALUE TEST SET COUNT : 605
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.65
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.80
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL
REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1669
REMARK 3 BIN R VALUE (WORKING SET) : 0.2420
REMARK 3 BIN FREE R VALUE : 0.2830
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 102
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2735
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 25
REMARK 3 SOLVENT ATOMS : 116
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 50.90
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.20
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 4.03000
REMARK 3 B22 (A**2) : 4.03000
REMARK 3 B33 (A**2) : -8.06000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.270
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL
REMARK 3 BOND ANGLES : NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL
REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : NULL
REMARK 3 BOND ANGLES (DEGREES) : NULL
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL
REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4
REMARK 4 3L3M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JAN-10.
REMARK 100 THE DEPOSITION ID IS D_1000056790.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 23-AUG-06
REMARK 200 TEMPERATURE (KELVIN) : 110.0
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12464
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500
REMARK 200 RESOLUTION RANGE LOW (A) : 81.600
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8
REMARK 200 DATA REDUNDANCY : 5.900
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.09600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8
REMARK 200 DATA REDUNDANCY IN SHELL : 6.00
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.32900
REMARK 200 <I/SIGMA(I)> FOR SHELL : 10.80
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: INHOUSE PARP-A904051 STRUCTURE
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 45.38
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION : PARP 60 MG/ML IN 50
REMARK 280 MM TRIS, 150 MM NACL, 1.5 MM DTT PH 7.5, 2 MM A861146 WELL
REMARK 280 SOLUTION : 0.8 M NACL, 1.8M AMMONIUM SULFATE CRYSTALS ARE SOAKED
REMARK 280 IN WELL SOLUTION CONTAINING 1 MM A927929 FROM 0.1 M DMSO STOCK
REMARK 280 CRYOPROTECTANT : 1.2 M NACL, 1.6 M AMMONIUM SULFATE, 20 %
REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z
REMARK 290 3555 -X+Y,-X,Z
REMARK 290 4555 Y,X,-Z
REMARK 290 5555 X-Y,-Y,-Z
REMARK 290 6555 -X,-X+Y,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 LYS A 1
REMARK 465 THR A 350
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 NE2 GLN A 192 NE2 GLN A 192 5555 2.15
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 80 C - N - CA ANGL. DEV. = 10.6 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 64 47.61 -63.06
REMARK 500 ASP A 65 -169.39 47.01
REMARK 500 SER A 66 -47.90 63.62
REMARK 500 LYS A 86 -11.05 76.10
REMARK 500 LYS A 87 154.45 75.40
REMARK 500 ASP A 122 35.01 -71.66
REMARK 500 ASP A 146 47.10 -87.87
REMARK 500 ALA A 162 -130.90 -102.37
REMARK 500 THR A 163 -39.73 -149.34
REMARK 500 ASN A 166 63.53 -102.85
REMARK 500 GLU A 183 94.89 -52.52
REMARK 500 CYS A 184 -30.50 175.04
REMARK 500 GLN A 192 32.25 -71.81
REMARK 500 HIS A 194 -168.44 -63.25
REMARK 500 ILE A 277 -93.27 -67.77
REMARK 500 SER A 278 -56.73 85.01
REMARK 500 LEU A 303 101.62 171.15
REMARK 500 ASP A 320 25.98 -78.11
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A92 A 351
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2RCW RELATED DB: PDB
REMARK 900 PARP-A620223
REMARK 900 RELATED ID: 2RD6 RELATED DB: PDB
REMARK 900 PARP-A861695
REMARK 900 RELATED ID: 3GJW RELATED DB: PDB
REMARK 900 PARP-A968427
REMARK 900 RELATED ID: 3GN7 RELATED DB: PDB
REMARK 900 PARP-A861696
DBREF 3L3M A 1 350 UNP P09874 PARP1_HUMAN 662 1011
SEQADV 3L3M ALA A 101 UNP P09874 VAL 762 ENGINEERED MUTATION
SEQRES 1 A 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS
SEQRES 2 A 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL
SEQRES 3 A 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS
SEQRES 4 A 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU
SEQRES 5 A 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP
SEQRES 6 A 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU
SEQRES 7 A 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU
SEQRES 8 A 350 ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET LEU
SEQRES 9 A 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU
SEQRES 10 A 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP
SEQRES 11 A 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL
SEQRES 12 A 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR
SEQRES 13 A 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP
SEQRES 14 A 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY
SEQRES 15 A 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN
SEQRES 16 A 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE
SEQRES 17 A 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO
SEQRES 18 A 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE
SEQRES 19 A 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS
SEQRES 20 A 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU
SEQRES 21 A 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS
SEQRES 22 A 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER
SEQRES 23 A 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA
SEQRES 24 A 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR
SEQRES 25 A 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR
SEQRES 26 A 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU
SEQRES 27 A 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR
HET A92 A 351 25
HETNAM A92 2-{2-FLUORO-4-[(2S)-PIPERIDIN-2-YL]PHENYL}-1H-
HETNAM 2 A92 BENZIMIDAZOLE-7-CARBOXAMIDE
FORMUL 2 A92 C19 H19 F N4 O
FORMUL 3 HOH *116(H2 O)
HELIX 1 1 PRO A 5 PHE A 16 1 12
HELIX 2 2 ASP A 17 TYR A 28 1 12
HELIX 3 3 PRO A 36 LEU A 40 5 5
HELIX 4 4 SER A 41 GLY A 62 1 22
HELIX 5 5 SER A 66 ILE A 79 1 14
HELIX 6 6 ASN A 93 GLY A 119 1 27
HELIX 7 7 ASP A 127 LEU A 136 1 10
HELIX 8 8 SER A 147 THR A 160 1 14
HELIX 9 9 LYS A 188 LEU A 193 5 6
HELIX 10 10 ARG A 204 THR A 206 5 3
HELIX 11 11 ASN A 207 GLY A 215 1 9
HELIX 12 12 MET A 239 ASN A 245 1 7
HELIX 13 13 PRO A 297 ASN A 300 5 4
HELIX 14 14 ASP A 332 ALA A 334 5 3
SHEET 1 A 6 THR A 138 VAL A 143 0
SHEET 2 A 6 TYR A 168 ARG A 180 -1 O ILE A 175 N VAL A 143
SHEET 3 A 6 VAL A 336 PHE A 348 -1 O LYS A 345 N GLU A 171
SHEET 4 A 6 ILE A 255 ALA A 264 -1 N GLY A 256 O LEU A 344
SHEET 5 A 6 ARG A 196 SER A 203 -1 N HIS A 201 O LEU A 259
SHEET 6 A 6 VAL A 306 ASP A 307 1 O ASP A 307 N ARG A 196
SHEET 1 B 4 ILE A 234 PHE A 236 0
SHEET 2 B 4 GLU A 327 VAL A 330 -1 O VAL A 330 N ILE A 234
SHEET 3 B 4 LYS A 284 GLY A 289 -1 N GLY A 289 O GLU A 327
SHEET 4 B 4 ASN A 267 LEU A 271 1 N TYR A 269 O SER A 286
SHEET 1 C 2 THR A 293 PRO A 295 0
SHEET 2 C 2 GLY A 313 SER A 315 -1 O ILE A 314 N THR A 294
SITE 1 AC1 14 GLN A 98 GLU A 102 ASP A 105 HIS A 201
SITE 2 AC1 14 GLY A 202 GLY A 227 TYR A 228 TYR A 235
SITE 3 AC1 14 PHE A 236 SER A 243 TYR A 246 HOH A 361
SITE 4 AC1 14 HOH A 378 HOH A 465
CRYST1 94.205 94.205 68.856 90.00 90.00 120.00 P 3 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010615 0.006129 0.000000 0.00000
SCALE2 0.000000 0.012257 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014523 0.00000